key: cord-0706703-0vm9wvn6
authors: Garoutte, A.; Santiago-Rodriguez, T. M.; Fehling, H. L.; Iwasiow, R.
title: Detection of SARS-CoV-2 in saliva using tailed amplicon sequencing
date: 2021-05-21
journal: nan
DOI: 10.1101/2021.05.19.21257217
sha: db97ac78bfbb0f36ec0eadbc7fae3b0116907934
doc_id: 706703
cord_uid: 0vm9wvn6

The most recent virus from the Coronaviridae family infecting humans, SARS-CoV-2, has resulted in a global pandemic. As part of the surveillance efforts, SARS-CoV-2 genomes are increasingly being made publicly available. Methods that include both short- and long-read sequencing have been used to elucidate SARS-CoV-2 genomes; however, many of these untargeted approaches may require deeper sequencing for greater genome coverage. For this reason, sequence capture or amplicon-based approaches for SARS-CoV-2 genome sequencing have been developed. The present study evaluated a modified sequence capture approach, namely, tailed amplicon sequencing, to determine SARS-CoV-2 near complete genome sequences from the saliva of infected individuals. Particularly, the suitability of saliva samples stored at room temperature using OMNIgene(R){middle dot}ORAL OME-505 was evaluated. The tailed amplicon sequencing approach poses the additional advantage of being a cost-effective method for library preparation. Different known SARS-CoV-2 variants were identified across the infected subjects, with an average of > 99.4% genome coverage. This methodology also enabled robust genomic surveillance using phylogenetic analyses. The present study supports the suitability of saliva stored at room temperature using collection devices for SARS-CoV-2 variant detection. Importantly, the present study supports the use of tailed amplicon sequencing approaches as an alternative, cost-effective method for SARS-CoV-2 detection in saliva for genomic surveillance.

Human saliva is home to over 700 microbial species, and serves as protection against The most recent virus from the Coronaviridae family known to infect humans, SARS-44

CoV-2 has also been identified in the saliva of infected individuals (Y. Li et al., 2020) . While the 45 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. proposed its use as an alternative to nasopharyngeal (NP) and oropharyngeal (OP) sample 51 collection, which pose additional discomfort and the need for trained personnel (Yoon et al., 52 2020). In addition, with the availability of at-home collection kits, subjects are more willing to 53 self-collect saliva(Valentine-Graves et al., 2020). Supervised, self-collected saliva has shown to 54 perform similarly to clinician-collected NP swabs for the detection of SARS-CoV-2 in terms of 55 virus detection and quantification (Noah et al., 2020) . Success of detection methods for SARS-56

CoV-2 depends, among many things, on the persistence and inactivation of the virus and nucleic 57 acids. For example, SARS-CoV-2 is detectable using reverse transcription PCR The gold standard for the detection of SARS-CoV-2 in any sample type is RT-PCR or 65 quantitative RT-PCR (RT-qPCR) (Takeuchi et al., 2020) . As with any PCR-based method, 66 success will depend on primer specificity; thus, the RNA target genome(s) sequence(s) should be 67 known in order to increase sensitivity (D. Li et al., 2020) . Other, less evaluated methods for the 68 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 21, 2021. ; https://doi.org/10.1101/2021.05.19.21257217 doi: medRxiv preprint detection and surveillance of SARS-CoV-2 in various sample types include high-throughput 69 sequencing. RNA high-throughput sequencing was originally used in combination with other 70 methods to identify the novel coronavirus in subjects suffering from pneumonia of unknown 71 origin, showing a similarity close to 90% to coronaviruses present in bats (Wu et al., 2020) . High-72 throughput sequencing can continue to be used for the surveillance of known and novel SARS-73

CoV-2 variants, and also to determine genetic diversity, which is usually not provided by RT-74 PCR or RT-qPCR (Pérez Cataluña et al., 2021). Two approaches have been developed for the 75 detection of SARS-CoV-2 in various sample types using high-throughput sequencing, namely, 76 untargeted and amplicon-based. Untargeted high-throughput sequencing provides the advantage 77 of detecting and monitoring both known and emerging SARS-CoV-2 variants, with the caveat of 78 requiring deeper sequencing to obtain the needed genome coverage for identification, making 79 this approach relatively more cost-prohibiting. Amplicon high-throughput sequencing, or 80 sequence capture methods, have been more widely applied for the detection of SARS-CoV-2 as 81 it represents a more cost-effective approach. One caveat of sequence capture approaches is the 82 failure to cover the entire viral genome as the primers usually cannot cover the genomic ends 83 (Gohl et al., 2020). 84

Approaches, such as the ARTIC network, have developed methods for amplicon pool 85 preparation for the sequencing of SARS-CoV-2 which involve a 'lab-in-a-suitcase' that can be 86 used in remote and resource-limited areas (https://artic.network/1-about.html). In the ARTIC 87 network protocol, the first cDNA strand is enriched by amplifying with two different pools of 88 primers. This generates amplicons tiling the virus genome, which are then subjected to either 89

Illumina or Oxford Nanopore library preparation and sequencing. More recently, a modification 90 to the ARTIC network protocol, known as tailed amplicon sequencing, has been developed to 91 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. tailed amplicon approach, the first cDNA strand is enriched using the ARTIC v3 primers. In this 94 case, the primers also contain adapter tails that allow sequencing libraries to be created through a 95 second indexing PCR. This, in turn, adds sample-specific barcodes and flow cell adapters. 96

Notably, this modification to the ARTIC protocol has not been extensively tested in saliva 97 samples. Therefore, the main aim of the present study was to evaluate the suitability of the 98 modified tailed amplicon sequencing protocol for the detection of SARS-CoV-2 and its ability to 99 discern potential variants in human saliva. Reference Laboratory, Inc. for testing using the CRL Rapid Response™ COVID-19 Test. After 106 testing, the remaining saliva samples collected and stabilized in the OMNIgene®•ORAL OME-107 505 devices, were stored at room temperature for up to 15 days prior to RNA extraction ( (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

The extracted RNA was then prepared and sequenced using previously described 117 methods in Gohl et al., 2020 (Gohl et al., 2020) . Briefly, the integrity of the extracted RNA was 118 analyzed as described previously. After RNA quality and integrity was checked, RT-qPCR was 119 also performed as described previously. RNA was also processed through the amplicon-based 120 sequencing method that utilizes adapter tails with the ARTIC network v3 primers, allowing for a 121 more efficient library preparation (Itokawa et al., 2020). Sequencing was also performed as 122 previously described using a MiSeq 600 cycle v3 kit following manufacturer's instructions. 123

After sequencing, the paired ends were joined using PANDAseq (Masella et al., 2012) . The present study evaluated a modified sequence capture approach, namely tailed 134 amplicon sequencing, for the detection of SARS-CoV-2 in the saliva of infected individuals [21] . 135

Detection of SARS-CoV-2 in the saliva of infected individuals, both symptomatic and 136 asymptomatic, has expanded the toolbox of methods for the detection and diagnostics of the 137 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. showed that the tailed amplicon sequencing approach was successful in the identification of 141 various SARS-CoV-2 variants in human saliva ( Table 1) . Results also showed the suitability of 142 OMNIgene®•ORAL OME-505 for sufficient SARS-CoV-2 RNA recovery for tailed amplicon 143 sequencing. Moreover, storage of saliva samples at room temperature using OMNIgene®•ORAL 144 OME-505 for up to 15 days further supports the capacity of this collection device to capture 145 saliva composition at the time of collection, essential for SARS-CoV-2 diagnostics and 146 surveillance. While upper and lower respiratory tract specimens were first to be recommended 147 for SARS-CoV-2 diagnosis, saliva has gained acceptance as a suitable, non-invasive sample 148 type. Indeed, saliva has been included in numerous FDA Emergency Use Authorizations for the 149 purpose of SARS-CoV-2 diagnosis, including CRL Rapid Response™. The OMNIgene®•ORAL 150 OME-505 saliva collection device, which has received EUA for SARS-CoV-2 sample collection, 151 allows for self-collection and to circumvent the need to store samples on ice or frozen. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 1 and Figure 1 ). In addition, the tailed amplicon method produced a relatively 164 uneven genome coverage balance. Indeed, this has been noted previously when comparing the 165 tailed amplicon method with the ARTIC network protocol (Gohl et al., 2020). One feasible 166 explanation for this unevenness in genome coverage is the better balance of the untailed primers 167 utilized in the ARTIC network protocol. Nevertheless, near complete SARS-CoV-2 genomes 168 were obtained in the present study, which may improve insights into virus mutations, evolution, 169 and adaptation (e.g., increased transmissibility and infectivity) compared to evolutionary 170 relationships across spike protein sequences alone. Unlike specific genes, complete or near 171 complete genomic sequences provide the most high-resolution information that allows 172 determination of variant and strain relatedness during outbreaks and pandemics. Thus, the 173 development of cost-effective and less time-consuming protocols to determine genomic 174 sequences is of importance. In addition, near complete genome information may also aid in the 175 classification of SARS-CoV-2 variants into strains. SARS-CoV-2 strain level resolution using 176 tailed amplicon sequencing approaches could potentially aid to bridge mutations within SARS-177 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (Figure 2) . Results show 189 that, overall, the tailed amplicon method described above is sensitive enough to resolve, not only 190 large-scale genomic differences across different clades, but also differences within clades. 191 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Figure  197 shows that the methodologies described above are sensitive enough to resolve, not only large-198 scale genomic differences across different clades, but also differences within clades. 

Longitudinal Study of Hepatitis A Infection by Saliva Sampling: The Kinetics of HAV Markers 282 in Saliva Revealed the Application of Saliva Tests for Hepatitis A Study

Primer design for quantitative real-time PCR for the emerging Coronavirus 285 SARS-CoV-2

Fast and accurate long-read alignment with Burrows-Wheeler transform

Saliva is a non-negligible factor in the spread of 289 COVID-19

PANDAseq: Paired-end 291 assembler for illumina sequences

Self-collected oral fluid and nasal 294 swabs demonstrate comparable sensitivity to clinician collected nasopharyngeal swabs for

No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted

Comparing HBV viral load in serum, Cerumen, and saliva and correlation with

HBeAg serum status in patients with chronic hepatitis B infection

Detection Of Genomic Variants Of SARS-CoV-2 Circulating In Wastewater By

Saliva-based pcr 304 tests for sars-cov-2 detection

Temporal profiles of viral 306 load in posterior oropharyngeal saliva samples and serum antibody responses during infection by

-2: an observational cohort study

At-home self-310 collection of saliva, oropharyngeal swabs and dried blood spots for sars-cov-2 diagnosis and 311 serology: Postcollection acceptability of specimen collection process and patient confidence in 312 specimens

Detection of SARS-associated 314 coronavirus in throat wash and saliva in early diagnosis

A new coronavirus associated with 317 human respiratory disease in China

All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted May 21, 2021. ; https://doi.org/10.1101/2021.05.19.21257217 doi: medRxiv preprint

The present study evaluated tailed amplicon sequencing as a suitable approach for the 204 detection of SARS-CoV-2 variants in the saliva of infected individuals collected using 205 OMNIgene®•ORAL OME-505. Near complete genome sequences were obtained using the 206 evaluated method, which in turn facilitated phylogenetic analysis with various SARS-CoV-2 207 variants. Near complete or complete genome sequences from SARS-CoV-2 variants continue to 208 be invaluable in disease control and prevention efforts during the COVID-19 pandemic; thus, the 209 evaluation of time-and cost-effective methods such as tailed amplicon sequencing is essential. Written informed consent and release statement has been obtained from the patient(s) to publish 225 this paper. 226 All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Khadse S V., Bajaj G, Vibhakar P, Nainani P, Ahuja R, Deep G. Evaluation of specificity and 272 All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted May 21, 2021. ; https://doi.org/10.1101/2021.05.19.21257217 doi: medRxiv preprint